BusinessGhana·3 min read·medium
AIDS 2026: Access key to ending AIDS by 2030
✦AI Summary
Experts at the AIDS 2026 conference in Brazil emphasized that equitable access to new long-acting HIV prevention medicines is now a greater challenge than scientific innovation. They urged governments to invest in community delivery systems to ensure technologies like Lenacapavir reach high-risk populations.
Access to new long-acting HIV prevention medicines, rather than scientific innovation, is now the main obstacle to ending AIDS by 2030, experts have said.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in